Cargando…

Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases

Parathyroid hormone-related peptide is a regulatory protein implicated in the pathogenesis of bone metastases, particularly in breast carcinoma. Parathyroid hormone-related peptide is widely expressed in primary prostate cancers but there are few reports of its expression in prostatic metastases. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bryden, A A G, Hoyland, J A, Freemont, A J, Clarke, N W, George, N J R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375222/
https://www.ncbi.nlm.nih.gov/pubmed/11875691
http://dx.doi.org/10.1038/sj.bjc.6600115
_version_ 1782154605980811264
author Bryden, A A G
Hoyland, J A
Freemont, A J
Clarke, N W
George, N J R
author_facet Bryden, A A G
Hoyland, J A
Freemont, A J
Clarke, N W
George, N J R
author_sort Bryden, A A G
collection PubMed
description Parathyroid hormone-related peptide is a regulatory protein implicated in the pathogenesis of bone metastases, particularly in breast carcinoma. Parathyroid hormone-related peptide is widely expressed in primary prostate cancers but there are few reports of its expression in prostatic metastases. The aim of this study was to examine the expression of parathyroid hormone-related peptide and its receptor in matched primary and in bone metastatic tissue from patients with untreated adenocarcinoma of the prostate. Eight-millimetre trephine iliac crest bone biopsies containing metastatic prostate cancer were obtained from 14 patients from whom matched primary tumour tissue was also available. Histological grading was performed by an independent pathologist. The cellular location of mRNA for parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor was identified using in situ hybridization with (35)S-labelled probe. Expression of parathyroid hormone-related peptide and its receptor was described as uniform, heterogenous or negative within the tumour cell population. Parathyroid hormone-related peptide expression was positive in 13 out of 14 primary tumours and in all 14 metastases. Receptor expression was evident in all 14 primaries and 12 out of 14 metastases. Co-expression of parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor was common (13 primary tumours, 12 metastases). The co-expression of parathyroid hormone-related peptide and its receptor suggest that autocrine parathyroid hormone-related peptide mediated stimulation may be a mechanism of escape from normal growth regulatory pathways. The high frequency of parathyroid hormone-related peptide expression in metastases is consistent with a role in the pathogenesis of bone metastases. British Journal of Cancer (2002) 86, 322–325. DOI: 10.1038/sj/bjc/6600115 www.bjcancer.com © 2002 The Cancer Research Campaign
format Text
id pubmed-2375222
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23752222009-09-10 Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases Bryden, A A G Hoyland, J A Freemont, A J Clarke, N W George, N J R Br J Cancer Clinical Parathyroid hormone-related peptide is a regulatory protein implicated in the pathogenesis of bone metastases, particularly in breast carcinoma. Parathyroid hormone-related peptide is widely expressed in primary prostate cancers but there are few reports of its expression in prostatic metastases. The aim of this study was to examine the expression of parathyroid hormone-related peptide and its receptor in matched primary and in bone metastatic tissue from patients with untreated adenocarcinoma of the prostate. Eight-millimetre trephine iliac crest bone biopsies containing metastatic prostate cancer were obtained from 14 patients from whom matched primary tumour tissue was also available. Histological grading was performed by an independent pathologist. The cellular location of mRNA for parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor was identified using in situ hybridization with (35)S-labelled probe. Expression of parathyroid hormone-related peptide and its receptor was described as uniform, heterogenous or negative within the tumour cell population. Parathyroid hormone-related peptide expression was positive in 13 out of 14 primary tumours and in all 14 metastases. Receptor expression was evident in all 14 primaries and 12 out of 14 metastases. Co-expression of parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor was common (13 primary tumours, 12 metastases). The co-expression of parathyroid hormone-related peptide and its receptor suggest that autocrine parathyroid hormone-related peptide mediated stimulation may be a mechanism of escape from normal growth regulatory pathways. The high frequency of parathyroid hormone-related peptide expression in metastases is consistent with a role in the pathogenesis of bone metastases. British Journal of Cancer (2002) 86, 322–325. DOI: 10.1038/sj/bjc/6600115 www.bjcancer.com © 2002 The Cancer Research Campaign Nature Publishing Group 2002-02-01 /pmc/articles/PMC2375222/ /pubmed/11875691 http://dx.doi.org/10.1038/sj.bjc.6600115 Text en Copyright © 2002 The Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical
Bryden, A A G
Hoyland, J A
Freemont, A J
Clarke, N W
George, N J R
Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases
title Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases
title_full Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases
title_fullStr Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases
title_full_unstemmed Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases
title_short Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases
title_sort parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375222/
https://www.ncbi.nlm.nih.gov/pubmed/11875691
http://dx.doi.org/10.1038/sj.bjc.6600115
work_keys_str_mv AT brydenaag parathyroidhormonerelatedpeptideandreceptorexpressioninpairedprimaryprostatecancerandbonemetastases
AT hoylandja parathyroidhormonerelatedpeptideandreceptorexpressioninpairedprimaryprostatecancerandbonemetastases
AT freemontaj parathyroidhormonerelatedpeptideandreceptorexpressioninpairedprimaryprostatecancerandbonemetastases
AT clarkenw parathyroidhormonerelatedpeptideandreceptorexpressioninpairedprimaryprostatecancerandbonemetastases
AT georgenjr parathyroidhormonerelatedpeptideandreceptorexpressioninpairedprimaryprostatecancerandbonemetastases